Table 1 Characteristics of the study population
Total study population (n = 59) | Responders (n = 29) | Nonresponders (n = 30) | p | |
|---|---|---|---|---|
Age (years), mean ± SD | 57 ± 18 | 60 ± 17 | 54 ± 18 | 0.23 |
Male, n (%) | 30 (51) | 15(62) | 15(50) | 0.09 |
McCabe group 0/1/2, n | 36/21/2 | 18/10/1 | 18/11/1 | 0.93 |
SAPS II, mean ± SD | 30 ± 16 | 34 ± 17 | 26 ± 14 | 0.06 |
Non-surgical/surgical admissions n (%) | 34/25(58/42) | 17/12(62/38) | 17/13(53/47) | 0.49 |
Medical history, n (%): | ||||
Hypertension | 23(39) | 11(38) | 12(40) | 0.71 |
Diabetes mellitus | 10(17) | 5(17) | 5(16) | 0.45 |
Cardiomyopathy | 10(17) | 4(14) | 6(20) | 0.68 |
- ischemic | 7(12) | 3(10) | 4(14) | 0.65 |
- hypertensive | 2(3) | 1(4) | 1(3) | 0.53 |
- obstructive | 1(2) | 0(0) | 1(3) | 1 |
Supraventricular arrhythmia | 2(3) | 1(3) | 1(3) | 0.47 |
COPD | 9(15) | 4(14) | 5(16) | 0.41 |
Pulmonary embolism | 1(2) | 0(0) | 1(3) | 1 |